微泰医疗-B(股票代码:02235)预计其本财年业绩将实现增长,主要得益于持续血糖监测系统及其他业务板块带来的收入贡献。公司产品组合的多元化发展为其财务表现提供了有力支撑。
微泰医疗-B(股票代码:02235)预计其本财年业绩将实现增长,主要得益于持续血糖监测系统及其他业务板块带来的收入贡献。公司产品组合的多元化发展为其财务表现提供了有力支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.